Reading CNXC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CNXC free→Reading CNXC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CNXC free→QuarterlyIQ Insights · CNXC
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Under the terms of the Investor Rights Agreement, dated as of March 29, 2023 (the “Investor Rights Agreement”), by and among Concentrix Corporation (the “Company”) and certain former stockholders of Marnix Lux SA, a public limited liability company ( société anonyme ) incorporated under the laws of the Grand Duchy of Luxembourg and the former parent…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As described below in
of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any Concentrix filing or report with the Securities and Exchange Commission, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing or report.
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in
Entry into a Material Definitive Agreement. On March 20, 2026, Concentrix Corporation (the “Company”), as servicer, entered into an amendment (the “Amendment”) to its accounts receivable securitization facility (as amended, the “Securitization Facility”) by and among Concentrix Receivables, Inc., a subsidiary of the Company, as borrower, PNC Bank, National Association, as administrative agent, and the group agents and the lenders party thereto. The Amendment provides for, among other things,…
Entry into a Material Definitive Agreement. On February 24, 2026, Concentrix Corporation (“Concentrix” or the “Company”) issued and sold $600,000,000 aggregate principal amount of its 6.500% Senior Notes due 2029 (the “Notes”). The Notes were sold in a registered public offering pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-273277), which became effective upon filing, and a Prospectus Supplement dated February 12, 2026, to a Prospectus dated July 17, 2023. The Com…
This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.
Other Events. On February 12, 2026, Concentrix Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named in Schedule 1 thereto, to issue and sell (the “Offering”) $600 million principal amount of its 6.500% Senior Notes due 2029 (the “Notes”). The Notes are being offered pursuant to a Registration Statement on Form S-3 (File No. 333-273277), w…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.